For clinicians (physicians and nurses): Oncology
Communicating timely and relevant news directly to healthcare professionals, from physicians to nurses and other allied health providers, keeps medical and scientific knowledge current.
- Cost Challenges in Developing New Oncology Drugs
- How to have a comfortable discussion on sexuality
- Drinking alcohol after diagnosis does not affect breast cancer
- Source of spiritual support influences EOL care decisions
- Mapping the future for cancer research: TCGA project
- Using genomic testing to steer clinical treatment decisions
- Outlook for Patient Support Philanthropies
- Anemia in Cancer Patients
- Influenza Vaccination for Cancer Patients
- Update on the Treatment of Pediatric Ewing Sarcoma
- Long-Term Follow-Up for Late Effects in Survivors of Childhood and Adolescent/Young Adult Cancers
- Emerging Therapies for Ovarian Cancer
- Integration of Palliative Care into Standard Oncology Care
- Guideline update leaves out novel tests in breast cancer
- TCGA data allows better predictions for colorectal cancer
- Integrating CAM therapies into oncology care
For oncology business professionals
The business side of oncology is important for supporting the development of promising therapies and getting them to patients.
- Oncology Business Dynamics Learning Series
; 12 learning modules on the business of oncology - Memorable Moments: The ASCO 2016 Experience for Physicians
- Hope and Hype: Questions Surround Liquid Biopsy
- Oncologists Become More Vocal About Rising Costs
- New Tools from NCCN and ASCO Address Value
- Emerging Role for Biomarkers and Implications for Care
- Translating Genomics into Action in Pediatric Cancer
- Consolidations Come with Concerns as NCI Cooperative Groups Restructure
- How do NCI Cooperative Groups Accomplish So Much with a Budget of about $150M from NCI?
- New Studies in Lung Cancer Prevention and Detection Reveal Positive Results
- The Business Case for Integrating Palliative Care into Oncology Practice
- Outlook for Patient Support Philanthropies
- Cost Challenges in Developing New Oncology Drugs
- Oncologists Become More Vocal About Rising Costs
- Emerging Role for Biomarkers and Implications for Care
- New Tools from ASCO and NCCN Address Value